NCT05547607 Clinical and Diagnostic Features of Endocarditis
| NCT ID | NCT05547607 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital of Ferrara |
| Condition | Endocarditis |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2022-09-09 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2022-09-09 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The burden of endocarditis has changed in the last years due to an increase in percutaneous valve procedures offered to a more fragile, and old population. Therefore an update in epidemiology data is necessary. The Observational prospective multicenter study to characterize the cLinical ANd DiagnoStiC feAtures of endocarditis in the contemPorary Era, (ENDO-LANDSCAPE study) is an observational, multicenter and international study. The study has two arms: retrospective and prospective. The retrospective arm will involve collecting data from patients discharged with a diagnosis of endocarditis between 2016 and 2022. The data obtained in the retrospective arm of the study will be utilized in a power calculation to determine the sample size for the prospective arm of the study. In the prospective phase in every participating center, all patients referred for echocardiography to assess for endocarditis and those with established endocarditis independent of the screened request will be eligible. Patients will then be stratified according to the presence or abscence of endocarditis. Those with an established diagnosis of endocarditis will be prospectively followed for outcomes.
Eligibility Criteria
Inclusion Criteria: * Patients above the age of 18 years. * all consecutive patients referred for echocardiography (transthoracic or transesophageal approach) to exclude endocarditis. * patients with a diagnosis of endocarditis on echocardiography independently by the request for the exam. Exclusion Criteria: * patient's refusal.
Contact & Investigator
Rita Pavasini, MD
PRINCIPAL INVESTIGATOR
University Hospital of Ferrara
Frequently Asked Questions
Who can join the NCT05547607 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Endocarditis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05547607 currently recruiting?
Yes, NCT05547607 is actively recruiting participants. Contact the research team at ldlvnc@unife.it for enrollment information.
Where is the NCT05547607 trial being conducted?
This trial is being conducted at Cona, Italy.
Who is sponsoring the NCT05547607 clinical trial?
NCT05547607 is sponsored by University Hospital of Ferrara. The principal investigator is Rita Pavasini, MD at University Hospital of Ferrara. The trial plans to enroll 500 participants.